JAMIE FUNG: Open Payments
NPI 1619747557 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 37 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,295 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $286 |
| PFIZER INC. | 8 | $142 |
| Lilly USA, LLC | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| CSL Behring | 2 | $41 |
| Merz Pharmaceuticals, LLC | 2 | $40 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| ACADIA Pharmaceuticals Inc | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
Products named: NURTEC ODT, QULIPTA, UBRELVY, BOTOX, KISUNLA, CAPLYTA, Hizentra, Xeomin.
Industry payments across OR — which companies pay providers there.
